Literature DB >> 10671232

Impact of in utero Th2 immunity on T cell deviation and subsequent immediate-type hypersensitivity in the neonate.

U Herz1, B Ahrens, A Scheffold, R Joachim, A Radbruch, H Renz.   

Abstract

It was the aim of this study to analyze the impact of maternal Th2 immune responses on onset and subsequent development of allergen-specific immunity and immediate-type hypersensitivity in early childhood. In a well characterized mouse model of Th2 immunity, BALB / c mice were sensitized to ovalbumin (OVA) before mating followed by allergen aerosol exposure during pregnancy. At the end of pregnancy mice developed allergen-specific Th2 / Th0 immunity and immediate-type hypersensitivity responses to OVA. T cells from these newborns, when restimulated with PMA / ionomycin, demonstrated a lowered capacity to produce IFN-gamma. To assess whether prenatal allergen exposure favors postnatal onset of a Th2-type immune response, these offspring were immunized to a novel antigen by a single injection of beta-lactoglobulin (BLG). In contrast to offspring from non-sensitized mothers, offspring from OVA-sensitized mice showed both higher anti-BLG immunoglobulin titers and higher frequencies of immediate-type skin test responses. Our data suggest that Th2 / Th0 immunity present during pregnancy has a decisive impact on shaping of the Th1 / Th2 T cell profile in the neonate. Furthermore, this effect favors the development of Th2 immune responses, when mice are exposed to a novel antigen during early childhood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671232     DOI: 10.1002/1521-4141(200002)30:2<714::AID-IMMU714>3.0.CO;2-P

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Adoptively transferred allergen-specific T cells cause maternal transmission of asthma risk.

Authors:  Cedric Hubeau; Irina Apostolou; Lester Kobzik
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

2.  IgE is expressed on, but not produced by, fetal cells in the human placenta irrespective of maternal atopy.

Authors:  E Sverremark Ekstrom; C Nilsson; U Holmlund; I van der Ploeg; B Sandstedt; G Lilja; A Scheynius
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

3.  Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice.

Authors:  Linda K Ellertsen; Unni C Nygaard; Ingrid Melkild; Martinus Løvik
Journal:  BMC Immunol       Date:  2010-03-01       Impact factor: 3.615

4.  Maternal transmission of resistance to development of allergic airway disease.

Authors:  Adam P Matson; Li Zhu; Elizabeth G Lingenheld; Craig M Schramm; Robert B Clark; Dawn M Selander; Roger S Thrall; Elena Breen; Lynn Puddington
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

Review 5.  Maternal influence in the transmission of asthma susceptibility.

Authors:  Edward G Barrett
Journal:  Pulm Pharmacol Ther       Date:  2007-07-12       Impact factor: 3.410

Review 6.  [Genetic immunization: new ways for protective and therapeutic vaccines against allergic diseases].

Authors:  Sandra Scheiblhofer; Richard Weiss; Josef Thalhamer
Journal:  Wien Med Wochenschr       Date:  2007

7.  Transplacental passage of interleukins 4 and 13?

Authors:  Robert H Lim; Lester Kobzik
Journal:  PLoS One       Date:  2009-03-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.